Recurrence Tumor: Clinical Trials

3 trials for Recurrence Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Completed 1
Phase 21Unknown 1

Follow Recurrence Tumor: new trials by email Literature Review of Recurrence Tumor trials Research Report on Recurrence Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy for the Treatment of Advanced Solid Tumor
TIL, Aldesleukin, Cyclophosphamide - Recurrence Tumor, Metastatic Cancer
Phase 1 / Phase 2UnknownTongji Hospital402020-04-282024-08-13
Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment
Moderate whole body hyperthermia using water-filtered IR-A-radiation - Head and Neck Neoplasms, Recurrence Tumor
Phase 1CompletedCharite University, Berlin, Germany102018-07-012020-05-05
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
chimeric antigen receptor T cells - Glioma, Malignant Glioma of Brain
Phase 1UnknownXuanwu Hospital, Beijing1002018-03-022021-06-15

Narrower conditions

Recurrence (3)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperthermia (1)  ·  Hypoxia (1)  ·  Neoplasm Metastasis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Disease Attributes (3)  ·  Neoplasms (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Body Temperature Changes (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Heat Stress Disorders (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neoplastic Processes (1)

Interventions

Cyclophosphamide (1)  ·  Immunotherapy, Adoptive (1)  ·  Interleukin-2 (1)  ·  aldesleukin (1)  ·  fludarabine (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Tongji Hospital (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

China (2)  ·  Germany (1)

Top investigators

Hui Wang, MD (1)  ·  Sebastian Zschaeck, MD (1)

Results publications

PMID 33626457, PMID 34235085